• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多药转运蛋白的机制。

Mechanisms of multidrug transporters.

作者信息

Bolhuis H, van Veen H W, Poolman B, Driessen A J, Konings W N

机构信息

Department of Microbiology, Groningen Biomolecular Sciences and Biotechnology Institute, University of Groningen, Haren, The Netherlands.

出版信息

FEMS Microbiol Rev. 1997 Aug;21(1):55-84. doi: 10.1111/j.1574-6976.1997.tb00345.x.

DOI:10.1111/j.1574-6976.1997.tb00345.x
PMID:9299702
Abstract

Drug resistance, mediated by various mechanisms, plays a crucial role in the failure of the drug-based treatment of various infectious diseases. As a result, these infectious diseases re-emerge rapidly and cause many victims every year. Another serious threat is imposed by the development of multidrug resistance (MDR) in eukaryotic (tumor) cells, where many different drugs fail to perform their therapeutic function. One of the causes of the occurrence of MDR in these cells is the action of transmembrane transport proteins that catalyze the active extrusion of a large number of structurally and functionally unrelated compounds out of the cell. The mode of action of these MDR transporters and their apparent lack of substrate specificity is poorly understood and has been subject to many speculations. In this review we will summarize our current knowledge about the occurrence, mechanism and molecular basis of (multi-)drug resistance especially as found in bacteria.

摘要

由多种机制介导的耐药性在各种传染病的药物治疗失败中起着关键作用。因此,这些传染病迅速再次出现,每年造成许多受害者。另一个严重威胁是真核(肿瘤)细胞中多药耐药性(MDR)的发展,在这种情况下,许多不同的药物无法发挥其治疗功能。这些细胞中发生MDR的原因之一是跨膜转运蛋白的作用,该蛋白催化大量结构和功能无关的化合物从细胞中主动排出。这些MDR转运蛋白的作用方式及其明显缺乏底物特异性的情况了解甚少,并且一直存在许多推测。在这篇综述中,我们将总结我们目前关于(多)药耐药性的发生、机制和分子基础的知识,特别是在细菌中发现的情况。

相似文献

1
Mechanisms of multidrug transporters.多药转运蛋白的机制。
FEMS Microbiol Rev. 1997 Aug;21(1):55-84. doi: 10.1111/j.1574-6976.1997.tb00345.x.
2
[Structures and functions of xenobiotic efflux pump P-glycoprotein and MRP--important molecular targets for cancer chemotherapy].
Gan To Kagaku Ryoho. 1997 Dec;24(15):2190-5.
3
Mutational analysis of ABC proteins.ABC蛋白的突变分析
Arch Biochem Biophys. 2008 Aug 1;476(1):51-64. doi: 10.1016/j.abb.2008.02.025. Epub 2008 Mar 5.
4
The homodimeric ATP-binding cassette transporter LmrA mediates multidrug transport by an alternating two-site (two-cylinder engine) mechanism.同二聚体ATP结合盒转运蛋白LmrA通过交替双位点(双缸发动机)机制介导多药转运。
EMBO J. 2000 Jun 1;19(11):2503-14. doi: 10.1093/emboj/19.11.2503.
5
[Multidrug resistance of cancer cells mediated by ABC superfamily transporters].[ABC超家族转运蛋白介导的癌细胞多药耐药性]
Nihon Rinsho. 1997 May;55(5):1024-9.
6
Multidrug transporters in prokaryotic and eukaryotic cells: physiological functions and transport mechanisms.原核细胞和真核细胞中的多药转运蛋白:生理功能和转运机制。
Mol Membr Biol. 2001 Jan-Mar;18(1):97-103. doi: 10.1080/09687680010030200.
7
Preface: the concept and consequences of multidrug resistance.前言:多重耐药性的概念及后果
Pflugers Arch. 2007 Feb;453(5):545-53. doi: 10.1007/s00424-006-0115-0. Epub 2006 Jul 22.
8
Reversal of multidrug resistance of tumor cells.肿瘤细胞多药耐药性的逆转
Anticancer Res. 2000 Nov-Dec;20(6B):4261-74.
9
[Molecular mechanisms for drug transport by MDR1/P-glycoprotein].[MDR1/P-糖蛋白介导药物转运的分子机制]
Tanpakushitsu Kakusan Koso. 1997 Jun;42(8):1263-72.
10
Multidrug resistance in parasites: ABC transporters, P-glycoproteins and molecular modelling.寄生虫中的多药耐药性:ABC转运蛋白、P-糖蛋白与分子建模
Int J Parasitol. 2005 Apr 30;35(5):555-66. doi: 10.1016/j.ijpara.2005.01.012.

引用本文的文献

1
Bactericidal activity of gallic acid against multidrug-resistant Mycobacterium tuberculosis.没食子酸对耐多药结核分枝杆菌的杀菌活性
Arch Microbiol. 2025 Aug 11;207(9):218. doi: 10.1007/s00203-025-04422-z.
2
ClpP2 proteasomes and SpxA1 determine Listeria monocytogenes tartrolon B hyper-resistance.ClpP2蛋白酶体和SpxA1决定了单核细胞增生李斯特菌对塔曲洛醇B的超抗性。
PLoS Genet. 2025 Apr 4;21(4):e1011621. doi: 10.1371/journal.pgen.1011621. eCollection 2025 Apr.
3
Challenges in Permeability Assessment for Oral Drug Product Development.
口服药物产品开发中渗透性评估的挑战。
Pharmaceutics. 2023 Sep 28;15(10):2397. doi: 10.3390/pharmaceutics15102397.
4
Integration of text mining and biological network analysis: Identification of essential genes in sulfate-reducing bacteria.文本挖掘与生物网络分析的整合:硫酸盐还原菌中必需基因的鉴定
Front Microbiol. 2023 Apr 13;14:1086021. doi: 10.3389/fmicb.2023.1086021. eCollection 2023.
5
Targeting Multidrug Resistance With Antimicrobial Peptide-Decorated Nanoparticles and Polymers.用抗菌肽修饰的纳米颗粒和聚合物靶向多重耐药性
Front Microbiol. 2022 Mar 31;13:831655. doi: 10.3389/fmicb.2022.831655. eCollection 2022.
6
Genome-Scale Metabolic Models and Machine Learning Reveal Genetic Determinants of Antibiotic Resistance in Escherichia coli and Unravel the Underlying Metabolic Adaptation Mechanisms.基因组规模代谢模型与机器学习揭示大肠杆菌抗生素耐药性的遗传决定因素并阐明潜在的代谢适应机制。
mSystems. 2021 Aug 31;6(4):e0091320. doi: 10.1128/mSystems.00913-20. Epub 2021 Aug 3.
7
Structural Insights into Transporter-Mediated Drug Resistance in Infectious Diseases.结构洞察传染性疾病中介体介导的药物耐药性。
J Mol Biol. 2021 Aug 6;433(16):167005. doi: 10.1016/j.jmb.2021.167005. Epub 2021 Apr 20.
8
Transcriptomic Evidence of Molecular Mechanisms Underlying the Response of Lactobacillus Plantarum WCFS1 to Hydroxytyrosol.植物乳杆菌WCFS1对羟基酪醇反应潜在分子机制的转录组学证据
Antioxidants (Basel). 2020 May 20;9(5):442. doi: 10.3390/antiox9050442.
9
Adapts to Antimicrobial Conjugated Oligoelectrolytes by Lipid Rearrangement and Differential Expression of Membrane Stress Response Genes.通过脂质重排和膜应激反应基因的差异表达适应抗菌共轭寡电解质。
Front Microbiol. 2020 Feb 14;11:155. doi: 10.3389/fmicb.2020.00155. eCollection 2020.
10
Dissection of Protonation Sites for Antibacterial Recognition and Transport in QacA, a Multi-Drug Efflux Transporter.质子化作用位点的剖析揭示了 QacA 作为一种多药外排转运蛋白的抗菌识别和转运机制。
J Mol Biol. 2019 May 17;431(11):2163-2179. doi: 10.1016/j.jmb.2019.03.015. Epub 2019 Mar 23.